Ludwig J. Marx.
Quantitative research

Systematic strategies, tested against chance.

I build and test trading rules for equities and futures. Each study ends as a working paper that says what holds, how sure I am, and what did not work.

Approach
Bottom line

Every paper opens with its result and a stated level of confidence. A finding that does not beat a random control is reported as a failure. It is not left out.

High
Holds out of sample, in both sub-periods and in the independent replication (R against QuantConnect).
Moderate
Holds in sample and in the replication; weaker or not yet tested out of sample.
Low
First finding, few cases or a single period. Stated so that nobody builds on it.

How the tests work

Working papers

Current studies

WP 2

Intraday Patterns in E‑mini Nasdaq Futures

in progress

Does an entry in the direction of the opening gap in the first hour, with a tight stop and an exit at the close, beat random entries after costs?

WP 3

Momentum under Full Review

planned

Does a momentum strategy with 20 or 50 positions beat random portfolios with the same number of positions and the same turnover, after costs and out of sample?

WP 4

Relative Weakness, Re-assessed

planned

An earlier version of this short-pair study rested on a faulty trade list. This paper rebuilds the list from scratch and asks whether any edge is left.

WP 5

Opening Gaps in Single Stocks

planned

Does the gap rule from Working Paper 2 carry over to single stocks, and for which gaps, stocks and market regimes?

Papers appear here as PDF when they are finished. All studies and their questions

About

Ten years in the Bundeswehr, six years in investment advice, a degree in political science. The habits I bring to research come from the first: give the result first, say how sure you are, and plan for what can go wrong.

More about me

Portrait of Ludwig J. Marx
Contact

I am looking for a role in research or portfolio management at an asset manager, and I take on project work on systematic strategies.

contact@ludwigjmarx.com LinkedIn